CIK 0001821825
- Large accelerated filer
Organon & Co.
Sign in to watch- Ticker
- OGN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 464838035
- Phone
- +1 551-430-6000
- Business address
- 30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-31 | Nisita Vittorio Head of Global Business Svcs | Grant or award | +2,862 | 9,967 | ||
| 2023-03-31 | Nisita Vittorio Head of Global Business Svcs | Shares withheld for taxes | −981 | $23.09 | $23K | 8,986 |
| 2023-03-31 | Nisita Vittorio Head of Global Business Svcs | Option exercise · Restricted Stock Units | −2,862 | 5,726 | ||
| 2023-03-31 | Nisita Vittorio Head of Global Business Svcs | Grant or award · Stock Option (right to buy) | +49,618 | 49,618 | ||
| 2023-03-31 | Morrissey Joseph T. Jr. Head of Manufacturing | Option exercise | +3,936 | 18,636 | ||
| 2023-03-31 | Morrissey Joseph T. Jr. Head of Manufacturing | Shares withheld for taxes | −1,122 | $23.09 | $26K | 17,514 |
| 2023-03-31 | Morrissey Joseph T. Jr. Head of Manufacturing | Option exercise · Restricted Stock Units | −3,936 | 7,873 | ||
| 2023-03-31 | Morrissey Joseph T. Jr. Head of Manufacturing | Grant or award · Restricted Stock Units | +23,384 | 23,384 | ||
| 2023-03-31 | Morrissey Joseph T. Jr. Head of Manufacturing | Grant or award · Stock Option (right to buy) | +83,969 | 83,969 | ||
| 2023-03-31 | Milligan Sandra Head of Research & Development | Option exercise | +5,964 | 26,825 | ||
| 2023-03-31 | Milligan Sandra Head of Research & Development | Shares withheld for taxes | −2,115 | $23.09 | $49K | 24,710 |
| 2023-03-31 | Milligan Sandra Head of Research & Development | Option exercise · Restricted Stock Units | −5,964 | 11,928 | ||
| 2023-03-31 | Milligan Sandra Head of Research & Development | Grant or award · Restricted Stock Units | +29,230 | 29,230 | ||
| 2023-03-31 | Milligan Sandra Head of Research & Development | Grant or award · Stock Option (right to buy) | +104,961 | 104,961 | ||
| 2023-03-31 | Fiedler Susanne Chief Commercial Officer | Option exercise | +4,771 | 22,166 | ||
| 2023-03-31 | Fiedler Susanne Chief Commercial Officer | Shares withheld for taxes | −1,520 | $23.09 | $35K | 20,646 |
| 2023-03-31 | Fiedler Susanne Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,771 | 9,543 | ||
| 2023-03-31 | Fiedler Susanne Chief Commercial Officer | Grant or award · Restricted Stock Units | +23,384 | 23,384 | ||
| 2023-03-31 | Fiedler Susanne Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +83,969 | 83,969 | ||
| 2023-03-31 | Falcione Aaron Chief Human Resources Officer | Option exercise | +3,578 | 13,365 |
Page 30 of 33 · 650 trades